Page 16 - Roche Diagnostics News Today

In an observational cohort study, Hongjiang Wu and colleagues analyse data from more than 1.5 million people Hong Kong between 2002 and 2018 and compare age- and sex-specific rates of all-cause and cause-specific hospital bed-day rates in those with and without type 2 diabetes.

Objectives To quantify mortality rates for patients successfully treated for hepatitis C in the era of interferon-free, direct acting antivirals and compare these rates with those of the general population. Design Population based cohort study. Setting British Columbia, Scotland, and England (England cohort consists of patients with cirrhosis only). Participants 21 790 people who were successfully treated for hepatitis C in the era of interferon-free antivirals (2014-19). Participants were div...

/PRNewswire/ -- Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced the expansion of their Global Business Partnership Agreement with Sysmex. As part of the...

Expanded alliance includes an agreement on eco social collaboration to jointly foster more sustainable diagnostic solutions, and the renewal of an agreement on hematology solutions for commercial and hospital

Ozona, Texas -based Ozona Organics, LLC is recalling select probiotic products for human and animal use citing potential to become contaminated with microbial growth, the U.

Roche Diagnostics India announced the launch of the Elecsys HCV Duo which is India’s first commercially available fully...

Major players in the cardiac biomarkers market are bioMerieux Inc., Bio-Rad Laboratories Inc., F. Hoffmann-La Roche AG, Siemens AG, Thermo Fisher...

/PRNewswire/ -- The "Global Magnetic Resonance Imaging Market: Analysis By Field Strength, By Architecture Type, By Application, By Region Size and Trends with...

[223+ Pages Report] The global thermal cyclers market size is expected to generate a revenue of USD 1369.37 million by 2030, with a CAGR of 7.32% during...

The U.S. Food and Drug Administration (FDA) issues safety alerts as needed to provide timely new safety information on human drugs, medical devices, vaccines, and other products, including biologics, dietary supplements, and cosmetics. The alerts are publicly available at the agency’s MedWatch website and contain “actionable information that may impact both treatment and diagnostic choices […]